A cancer vaccine is reducing the chances that melanoma patients’ tumors return
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck. (AP Video/Lekan

This headline comes from the wire. Read the full story at the original publisher:
Continue reading at Associated Press →



